BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-54

  1. 231 Posts.
    lightbulb Created with Sketch. 38
    Interestnig that the Aus arm of the study was significant with a P=.007 for the 5% arm . The American arm of the study however showed no difference compared with placebo. Why ? This requires more digging before we can form any judgement but if they were not confident they would not procedure to Phase 3
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.